A Randomized, 3 arm, multicenter Phase III study

  • Yee, Douglas (PI)
  • Haddad, Tufia (Prior Principal Investigator)

Project: Research project

Project Details

Description

A Randomized, 3 arm, multicenter Phase III study to Evaluate the Efficacy and the Safety of T-DM1 combinded with Pertuzumab or T-DM1 combined with Pertuzumab-Placebo (blinded for Pertuzumab)vs the combination of Trastuzumab plus Taxane, as first line t
StatusFinished
Effective start/end date5/19/106/30/17

Funding

  • HOFFMANN-LA ROCHE PHARMACEUTICALS